Thanks for sharing. I've kept an eye on RPMGX for exposure in the MCG space. Less "growthy" that some of the other funds in this space with nose bleed valuations. Even at $11B in outflows last year, the fund is still large in my opinion at $39B. Capacity constraints still remain one of my concerns with this fund.
